NCT06347835View on ClinicalTrials.gov

Biomarker Identification and Nutritional Intervention of Primary Sarcopenia Based on Gut-muscle Axis

NANot yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

January 31, 2026

Conditions
Sarcopenia
Interventions
DIETARY_SUPPLEMENT

symbiotic

The intervention is made up of multiple probiotics and prebiotics (20g/d) and dietary pattern modification.

DIETARY_SUPPLEMENT

whey protein

The intervention is made up of whey protein supplements (20g/d) and dietary pattern modification.

DIETARY_SUPPLEMENT

symbiotic placebo

The intervention is made up of maltodextrin (20g/d) and dietary pattern modification.

DIETARY_SUPPLEMENT

whey protein placebo

The intervention is made up of maltodextrin (20g/d) and dietary pattern modification.

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER

NCT06347835 - Biomarker Identification and Nutritional Intervention of Primary Sarcopenia Based on Gut-muscle Axis | Biotech Hunter | Biotech Hunter